Faculty Opinions recommendation of PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma.

2016 ◽  
Author(s):  
Michael Postow
Keyword(s):  
Differential Expression ◽  
Stage Iii ◽  
Mutation Burden ◽  
Stage Iii Melanoma ◽  
Immune Related Genes

PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma

2016 ◽  
Vol 22 (15) ◽  
pp. 3915-3923 ◽  
Author(s):  
Jason Madore ◽  
Dario Strbenac ◽  
Ricardo Vilain ◽  
Alexander M. Menzies ◽  
Jeen Y. H. Yang ◽  
...  
Keyword(s):  
Differential Expression ◽  
Stage Iii ◽  
Mutation Burden ◽  
Stage Iii Melanoma ◽  
Immune Related Genes

Differential expression of immune-related genes in the skin of zebrafish screened by cDNA microarray

2013 ◽  
Vol 18 (6) ◽  
pp. 1226-1233 ◽  
Author(s):  
Aijun LÜ ◽  
Xiucai HU ◽  
Jun XUE ◽  
Yi WANG ◽  
Jinnian LI
Keyword(s):  
Differential Expression ◽  
Cdna Microarray ◽  
Immune Related Genes

scholarly journals Single-center real-life experience with low-dose ipilimumab monotherapy in adjuvant setting for patients with stage III melanoma

2019 ◽  
Vol 29 (6) ◽  
pp. 648-654 ◽  
Author(s):  
Joanna Mangana ◽  
Florentia Dimitriou ◽  
Ralph Braun ◽  
Sabine Ludwig ◽  
Reinhard Dummer ◽  
...  
Keyword(s):  
Low Dose ◽  
Life Experience ◽  
Real Life ◽  
Stage Iii ◽  
Adjuvant Setting ◽  
Single Center ◽  
Stage Iii Melanoma

Bilateral facial neuritis associated with dabrafenib and trametinib after failure of neoadjuvant immunotherapy for stage III melanoma

2021 ◽  
Author(s):  
Andrew T. Li ◽  
Aung Min Maw ◽  
Edward Hsiao ◽  
Sydney Ch'ng ◽  
Georgina V. Long ◽  
...  
Keyword(s):  
Stage Iii ◽  
Neoadjuvant Immunotherapy ◽  
Stage Iii Melanoma

scholarly journals Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

The Lancet ◽  
2008 ◽  
Vol 372 (9633) ◽  
pp. 117-126 ◽  
Author(s):  
Alexander MM Eggermont ◽  
Stefan Suciu ◽  
Mario Santinami ◽  
Alessandro Testori ◽  
Wim HJ Kruit ◽  
...  
Keyword(s):  
Adjuvant Therapy ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Phase Iii ◽  
Stage Iii ◽  
Phase Iii Trial ◽  
Pegylated Interferon Alfa ◽  
Stage Iii Melanoma ◽  
Resected Stage

PP 3 S-100B concentrations predict disease specific survival in AJCC Stage III melanoma patients

2011 ◽  
Vol 47 ◽  
pp. S21
Author(s):  
S. Kruijff ◽  
E. Bastiaannet ◽  
M. Speijers ◽  
I. Kema ◽  
R. van Ginkel ◽  
...  
Keyword(s):  
Stage Iii ◽  
Disease Specific Survival ◽  
Ajcc Stage ◽  
Melanoma Patients ◽  
Stage Iii Melanoma ◽  
Disease Specific
Sign in / Sign up

Export Citation Format

Share Document